Recent advances in the treatment of gynecologic cancers are promising, and education is needed to ensure that both oncology and primary care clinicians, including OB/GYNs, have a thorough knowledge of biomarkers, current and emerging therapies, and how the latest clinical …
Health inequities in oral health care significantly impact underserved and minority populations, leading to disparities in diagnosis, treatment, and outcomes. Studies have shown that racial and ethnic minorities often receive lower quality dental care, face higher rates of oral diseases, …
With this CME Outfitters Briefcase activity, we will delve into a patient case interaction, set in a primary care/women’s health setting, to explore critical concepts in migraine management. Despite advancements, unmet needs persist for patients with migraine, especially among women, …
In this CME Outfitters Briefcase activity, we will examine a patient case interaction within an emergency department (ED) setting to explore critical concepts in migraine management. Despite advancements, unmet needs persist for patients with migraine, particularly among women, marginalized communities, …
Treatment guidelines for chronic inflammatory demyelinating polyneuropathy (CIDP), an autoimmune neuro-muscular condition impacting the myelin that insulates and protects peripheral nerves causing mobility and sensory impairment, have been in place for many years with new treatment approvals being scarce. Newly …
Biomarker or molecular testing to help oncologists match patients with the best cancer treatment can be challenging in the community oncology setting and for patients in underserved communities. At present, patients with cancer in racially or ethnically underserved communities are …
Unmet needs persist for patients with migraine, particularly for women and those in marginalized communities or who present to emergency care settings. To address these disparities, diagnosis and implementation of appropriate pharmacotherapy while factoring in social drivers of health and …
Ulcerative colitis (UC) affects around three million people in the United States. Delays in treatment coverage approval, costs of managing the disease, and uncertainties around new treatment options significantly impact how well patients react to treatment, and short- and long-term …
Despite the associated high probability of fetal risks in pregnant patients, mycophenolate remains one of the most commonly used immunosuppressants for patients receiving a solid organ transplant (SOT). To help combat the risks associated with mycophenolate treatment, the ongoing FDA …